Details of the Drug

General Information of Drug (ID: DMUSPW5)

Drug Name

NCO-48

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis B virus Polymerase (HBV P)	TTT4SY6	Q67889_HBV	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04629976) Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B. U.S. National Institutes of Health.
2	Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects